Glutathione-S-transferase M1 and codon 72 p53 polymorphisms in a northwestern Mediterranean population and their relation to lung cancer susceptibility

Cancer Epidemiology Biomarkers and Prevention

Volumn 5, Issue 5, 1996, Pages 337-342

  To Figueras, Jordi ^a,b   Gené, Manel ^a   Gómez Catalán, Jesús ^a   Galán, Carmen ^a   Firvida, José ^a   Fuentes, Miriam ^a   Rodamilans, Miquel ^a   Huguet, Emili ^a   Estapé, Jordi ^a   Corbella, Jacint ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE;

ADULT; AGED; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CHROMOSOME POLYMORPHISM; CIGARETTE SMOKING; CODON; GENOTYPE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MEDITERRANEAN SEA; POPULATION RESEARCH; PRIORITY JOURNAL;

ADENOCARCINOMA; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALLELES; AMINO ACID SEQUENCE; ARGININE; CARCINOMA; CARCINOMA, SMALL CELL; CODON; FEMALE; GENE DELETION; GENE FREQUENCY; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; JAPAN; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROLINE; RISK FACTORS; SMOKING; SPAIN;

EID: 19144368819     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Gonzalez, F. Genetic polymorphism and cancer susceptibility. Cancer Res., 55: 710-715, 1995.
2. Mannervik, B., and Danielson, U. H. Glutathione transferases structure and catalytic activity. CRC Crit. Rev. Biochem., 23: 281-334, 1988.
3. Seidegard, J., Voracheck, W. R., Pero, R. D., and Pearson, W. R. Hereditary differences in the expression of the human glutathione transferase active on Irans stilbene oxide are due to a gene deletion. Proc. Natl. Acad. Sci. USA, 85: 7293-7297, 1988.
4. Bell, D. A., Thompson, C. L., Taylor, J., Miller, C. R., Perera, F., Hsieh, L. L., and Lucier, G. W. Genetic monitoring of human polymorphic cancer susceptibility genes by polymerase chain reaction: application to glutathione transferase μ. Environ. Health Perspect., 98: 113-117, 1992.
5. Seidegard, J., Pero, R., Markowitz, M., Roush, G., Miller, D., and Beattie, E. J. Isoenzymes of glutathione transferase (class Mu) as a marker for the susceptibility to lung cancer: a follow up study. Carcinogenesis (Lond.), 11: 33-36, 1990.
6. Nazar-Stewart, V., Motulsky, A. G., Eaton, D. L., White, E., Hornung, S. K., Leng, Z. T., Stapleton, P., and Weiss, N. S. The glutathione S-transferase mu polymorphism as a marker for susceptibility to lung carcinoma. Cancer Res., 53: 2313-2318, 1993.
7. Hayashi, S. I., Watanabe, J., and Kawajiri, K. High susceptibility to lung cancer analyzed in terms of combined genotypes of P4501A1 and Mu-class glutathione 5-transferase genes. Jpn. J. Cancer. Res., 83: 866-870, 1992.
8. Alexandrie, A. K., Sundberg, M. I., Seidegard, J., Tornling, G., and Ranung, A. Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types. Carcinogenesis (Lond.), 15: 1785-1790, 1994.
9. Hirvonen, A., Husgafvel-Pursiainen, K., Anttila, S., and Vainio, H. The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung. Carcinogenesis (Lond.), 14: 1479-1481, 1993.
10. Kihara, M., Kihara, M., and Noda, K. Lung cancer risk of GSTM null genotype is dependent on the extent of tobacco smoke exposure. Carcinogenesis (Lond.), 15: 415-418, 1994.
11. Zhong, S., Howie, A. F., Ketterer, B., Taylor, J., Hayes, J. D., Beckett, G. J., Wathen, C. G., Wolf, C. R., and Spurr, N. K. Glutathione S-transferase μ locus: use of genotyping and phenotyping assays to assess association with lung cancer susceptibility. Carcinogenesis (Lond.), 12: 1533-1537, 1991.
12. Brockmöller, J., Gross, D., Kerb, R., Drakoulis, N., and Roots, I. Correlation between trans-stilbene oxide-glutathione conjugation activity and the deletion mutation in the glutathione S-transferase class μ gene detected by polymerase chain reaction. Biochem. Pharmacol., 43: 647-650, 1992.
13. London, S. J., Daly, A. K., Cooper, J., Navidi, W. C., Carpenter, C. L., and Idle, J. R. Polymorphism of glutathione S-transferase M1 and lung cancer risk among African-Americans and Caucasians in Los Angeles County, California. J. Natl. Cancer Inst., 85: 1246-1252, 1995.
14. Greenblatt, M. S., Bennett, W. P., Hollstein, M., and Harris, C. C. Mutations in the p53 gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 55: 4855-4878, 1994.
15. Matlashewski, G. I., Tuck, S., Pim, D., Lamb, P., Schneider, J., and Crawford, L. V. Primary structure polymorphism at amino acid residue 72 of human p53. Mol. Cell. Biol., 7: 961-963, 1987.
16. Buchman, V. L., Chumakov, P. M., Ninkina, N. N., Samarina, O. P., and Georgiev, G. P. A variation in the structure of the protein-coding region of the human p53 gene. Gene (Amst.), 70: 245-252, 1988.
17. de la Calle-Martin, O., Fabregat, V., Romero, M., Soler, J., Vives, J., and Yagüe, J. AccII polymorphism of the p53 gene. Nucleic Acids Res., 18: 4963, 1990.
18. Ara, S., Lee, P. S. Y., Hansen, M. F., and Saya, H. Codon 72 polymorphism of the TP53 gene. Nucleic Acids Res., 18: 4961, 1990.
19. Kawajiri, K., Nakachi, K., Imai, K., Watanabe, J., and Hayashi, S. I. Germ lines polymorphisms of p53 and CYP1A1 genes involved in human lung cancer. Carcinogenesis (Lond.), 14: 1085-1089, 1993.
20. Weston, A., Perrin, L. S., Forrester, K., Hoover, R. N., Trump, B. F., Harris, C. C., and Caporaso, N. E. Allelic frequency of a p53 polymorphism in human lung cancer. Cancer Epidemiol., Biomarkers & Prev., 1: 481-483, 1994.
21. Weston, A., Ling-Cawley H., Caporaso, N. E., Bowman, E. D., Hoover, R. N., Trump, B. F., and Harris, C. C. Determination of the allelic frequencies of an L-myc and p53 polymorphism in human lung cancer. Carcinogenesis (Lond.), 15: 583-587, 1994.
22. Jin, X., Wu, X., Roth, J. A., Amos, C. I., King, T. M., Branch, C., Honn, S. E., and Spitz, M. R. Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype. Carcinogenesis (Lond.), 16: 2205-2208, 1995.
23. Birgander, R., Själander, A., Rannug, A., Alexandrie, A. K., Ingelman-Sundberg, M., Seidegard, J., Tomling, G., Beckman, G., and Beckman, L. p53 polymorphisms and haplotypes in lung cancer. Carcinogenesis (Lond.), 16: 2233-2236, 1995.
24. Gené, M., Moreno, P., Huguet, E., Corbella, J., and Mezquita, J. D1S80 polymorphism, including a new variant in a population sample from Barcelona (Spain) using PCR. Am. J. Hum. Biol., 5: 691-695, 1993.
25. Gené, M., Huguet, E., Sánchez-Garcia, C., Moreno, P., Corbella, J., and Mezquita, J. Suitability of the YNZ22 (D17S5) VNTR polymorphism for legal medicine investigations in the population of Catalonia (Spain). Int. J. Leg. Med., 107: 222-224, 1995.
26. Auxbel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Strahl, K. (eds.). Current Protocols in Molecular Biology, pp. 2.2.1-2.2.3. New York: Greens Publishing Associates and Wiley-Interscience, 1987.
27. Groppi, A., Coutelle, C., Fleury, B., Iron, A., Begueret, J., and Couzigou P. Glutathione S-transferase class mu in French alcoholic cirrhotic patients. Hum. Genet., 87: 628-630, 1993.
28. Nakachi, K., Imai, K., Hayashi, S., and Kawajiri, K. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility of lung cancer in relation to cigarette dose in a Japanese population. Cancer. Res., 53: 2994-2999, 1993.
29. Hayashi, S., Watanabe, J., and Kawajiri, K. High susceptibility to lung cancer analyzed in terms of combined genotypes of P450IA1 and mu-class glutathione S-transferase genes. Jpn. J. Cancer Res., 83: 866-870, 1992.